Allergan

A Covid-19 threat to business acquisitions
A Covid-19 threat to business acquisitions
EP Vantage
COVID-19
M&A
AbbVie
Allergan
Arya Sciences
Immatics
AcelRx
Tetraphase
Gilead Sciences
Forty Seven
Thermo Fisher
Stryker
Wright Medical
Flag link:
AbbVie and Allergan Sign Divestiture Consent Decree with FTC, Move Closer to Finalizing Merger
AbbVie and Allergan Sign Divestiture Consent Decree with FTC, Move Closer to Finalizing Merger
BioSpace
AbbVie
Allergan
FTC
M&A
Flag link:
AbbVie, Allergan merger may face regulatory delay due to COVID-19: report
AbbVie, Allergan merger may face regulatory delay due to COVID-19: report
Fierce Pharma
AbbVie
Allergan
FTC
M&A
COVID-19
Flag link:
Amgen/Allergan’s rituximab biosimilar could be $4bn blockbuster
Amgen/Allergan’s rituximab biosimilar could be $4bn blockbuster
Pharmaforum
Amgen
Allergan
biosimilars
Roche
rituximab
Flag link:
10 Drugs Expected to Enter the Market This Year Could be Blockbusters, Analysis Says
10 Drugs Expected to Enter the Market This Year Could be Blockbusters, Analysis Says
BioSpace
biosimilars
Amgen
Allergan
Roche
Rituxan
Bristol-Myers Squibb
ozanimod
risdiplam
Biomarin
valrox
Flag link:
FDA approves Allergan’s biodegradable glaucoma implant drug
FDA approves Allergan’s biodegradable glaucoma implant drug
PM Live
Allergan
Durysta
FDA
glaucoma
Flag link:
AbbVie and Allergan finally set (rough) date for wedding as one parent agrees to the match
AbbVie and Allergan finally set (rough) date for wedding as one parent agrees to the match
Endpoints
AbbVie
Allergan
M&A
Flag link:
Biohaven scores CGRP OK for acute migraine — can the commercial team catch up with Allergan on its debut?
Biohaven scores CGRP OK for acute migraine — can the commercial team catch up with Allergan on its debut?
Endpoints
Biohaven
FDA
migraines
Nurtec
Allergan
AbbVie
Ubrelvy
Flag link:
Allergan accused of misleading CoolTone marketing in new lawsuit from BTL
Allergan accused of misleading CoolTone marketing in new lawsuit from BTL
Fierce Pharma
Allergan
BTL
CoolTone
devices
EmSculpt
Flag link:
In final report, ICER appears to have a change of heart on new acute migraine therapies
In final report, ICER appears to have a change of heart on new acute migraine therapies
Endpoints
ICER
migraines
Biohaven
Allergan
ubrogepant
rimegepant
Eli Lilly
Lasmiditan
Flag link:
Allergan Sued by BTL Over False Advertising Claims Regarding Muscle-Toning Product
Allergan Sued by BTL Over False Advertising Claims Regarding Muscle-Toning Product
Motley Fool
Allergan
BTL
advertising
Flag link:
Allergan's Botox still a physician favorite for migraine despite CGRP push: analyst
Allergan's Botox still a physician favorite for migraine despite CGRP push: analyst
Fierce Pharma
Allergan
Botox
migraines
physicians
neurologists
CGRPs
Flag link:
Allergan targets filler-prone millennials with new Juvederm lip campaign
Allergan targets filler-prone millennials with new Juvederm lip campaign
Fierce Pharma
Allergan
Juvederm
millennials
DTC ads
Flag link:
How Allergan Beat Estimates in What's Likely Its Last Quarterly Update
How Allergan Beat Estimates in What's Likely Its Last Quarterly Update
Motley Fool
Allergan
earnings
Flag link:
Aerie Pharmaceuticals hires former Allergan, Alcon exec to help lead clinical, medical affairs
Aerie Pharmaceuticals hires former Allergan, Alcon exec to help lead clinical, medical affairs
Fierce Biotech
Aerie Pharmaceuticals
Allergan
Alcon
medical affairs
Flag link:
Lilly's migraine reliever Reyvow cleared for launch, beating Allergan's rival Ubrelvy to market
Lilly's migraine reliever Reyvow cleared for launch, beating Allergan's rival Ubrelvy to market
Fierce Pharma
migraines
Eli Lilly
Reyvow
Allergan
Ubrelvy
Flag link:
Allergan, Merck KGaA and Sai Life Sciences Invest in New Global Manufacturing Facilities
Allergan, Merck KGaA and Sai Life Sciences Invest in New Global Manufacturing Facilities
BioSpace
Allergan
Merck KGaA
Sai Life Sciences
drug manufacturing
Flag link:
Allergan unveils new Botox plant ahead of $63B AbbVie merger
Allergan unveils new Botox plant ahead of $63B AbbVie merger
Fierce Pharma
AbbVie
Allergan
Botox
Ireland
drug manufacturing
Flag link:
Allergan Offloads Two Drugs to Secure Approval of Merger With AbbVie
Allergan Offloads Two Drugs to Secure Approval of Merger With AbbVie
Xconomy
Allergan
AbbVie
AstraZeneca
M&A
Nestle
Flag link:
AbbVie nears Allergan lockup with EU antitrust approval—and only one selloff required
AbbVie nears Allergan lockup with EU antitrust approval—and only one selloff required
Fierce Pharma
AbbVie
Allergan
antitrust
M&A
brazikumab
Europe
Flag link:

Pages